Advertisement
U.S. markets closed

Strainsforpains, Inc. (EBYH)

Other OTC - Other OTC Delayed Price. Currency in USD
0.15000.0000 (0.00%)
At close: 02:10PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1500
Open0.1500
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1500 - 0.1500
52 Week Range0.1300 - 0.2970
Volume1,500
Avg. Volume1,250
Market Cap1.784M
Beta (5Y Monthly)0.03
PE Ratio (TTM)N/A
EPS (TTM)-0.0300
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for EBYH

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • E-BUY HOME INC
    Analyst Report: Schlumberger LimitedSLB is the largest oilfield service firm in the world, with expertise in myriad disciplines, including reservoir performance, well construction, production enhancement, and more recently, digital solutions. It maintains a reputation as one of the industry’s leading innovators, which has earned it dominant share in numerous end markets.
    Rating
    Fair Value
    Economic Moat
    3 days agoMorningstar
View more
  • GlobeNewswire

    Strainsforpains CEO Simon Shainberg Discusses Entering 191 Billion Dollar Anti-Inflammatory Market, and Strategic Partnership and Research Potential with GenBio Corp.

    NEW YORK, March 14, 2024 (GLOBE NEWSWIRE) -- Strainsforpains, Inc. (OTC PINK:EBYH) Strainsforpains, Inc. has entered into a strategic partnership with GenBio to license potentially new anti-inflammatory compounds to be included in Strainsforpains CBD branded products. Strainsforpains is also progressing towards its change of symbol on the OTC Markets, with its upcoming audited financials within 2024. “Our company is very involved, and has been for a long time, in the health and wellness space,”

  • GlobeNewswire

    Strainsforpains, Inc. Investors Update: Strainsforpains, Inc. Showing Strong Revenue Growth

    NEW YORK, March 07, 2024 (GLOBE NEWSWIRE) -- -- (E-Buy Homes, Inc. DBA/Strainsforpains, Inc.) (OTC Markets: EBYH) Strainsforpains, Inc. is pleased to announce the successful acquisition of a substantial $130,000 distribution order from Exploration Solutions, LLC, (ESLLC) a Brooklyn, NY based distributor of health and wellness products. The initial order, comprising over 3000 units of CBD body cream, is set to be distributed across pharmacies and wellness centers in the Tri State area. Notable lo

  • Newsfile

    StrainsForPains, Inc. Discusses Inspiration, App Technology and CBD Market Entrance with The Stock Day Podcast

    Phoenix, Arizona--(Newsfile Corp. - February 29, 2024) - The Stock Day Podcast welcomed StrainsForPains, Inc. (OTC Pink: EBYH) ("the Company"), a medical marijuana recommendation engine that guides patients to the appropriate cannabinoid levels, medical cannabis strains, and consumption methods for their specific ailment. CEO of the Company, Simon Shainberg, joined Stock Day host Matthew Dunehoo.Dunehoo began the interview by asking about Mr. Shainberg's background. "I am a graduate of the State